OSCR
Oscar Health, Inc.
OSCR's fundamentals are strong: revenue grew 55% and its operating margin went from −1.9% to 5.4%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
POCI
Precision Optics Corporation, Inc.
There isn't enough reported data to score POCI yet.
OSCR Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Strong | |
| Strong |
OSCR's revenue, profitability, cash flow and balance sheet are all currently healthy.
POCI Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Under pressure | |
| Weak |
POCI's revenue is currently strong, but its profitability, cash flow and balance sheet are under pressure.
OSCR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $31.94 | — |
| Current | 13x | $31.94 | — |
| Cheap | 21x | $52.73 | +65% |
| Fair | 35x | $87.23 | +173% |
| Expensive | 130x | $322 | +907% |
Historical ranges are pointers, not guarantees.
OSCR's PE is 13x, but its earnings don't support one, so it isn't a reliable read right now.
POCI PE Valuation
POCI has no meaningful PE right now: it lost money over the past year.
OSCR Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for OSCR, with profitability improving.
POCI Forward outlook
There aren't enough analyst estimates for POCI to show an outlook.
OSCR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.61 | +5.6% |
| Q3 2026 | $2.47 | +$3.47 |
| Q2 2026 | $1.45 | +$2.14 |
| Q1 2026 | -$0.54 | -235% |
| Q4 2025 | -$1.69 | -1790% |
| Q3 2025 | -$1.00 | -$0.92 |
| Q2 2025 | -$0.69 | -$0.54 |
| Q1 2025 | $0.40 | +$0.82 |
| Q4 2024 | $0.10 | +$1.32 |
OSCR has the stronger earnings trend. Trailing diluted EPS is up 147% for OSCR versus POCI down 172%.
POCI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q1 2026 | -$0.64 | +$0.25 |
| Q4 2025 | -$0.93 | -$0.29 |
| Q3 2025 | -$0.85 | -$0.23 |
| Q2 2025 | -$0.85 | -$0.36 |
| Q1 2025 | -$0.89 | -$0.61 |
| Q4 2024 | -$0.64 | -$0.34 |
| Q3 2024 | -$0.62 | -$0.56 |
| Q2 2024 | -$0.49 | -2550% |
POCI lost $0.64 per share over the past year, a smaller loss than the year before.
OSCR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $5.1B | +72% |
| Q2 2026 | $4.9B | +70% |
| Q1 2026 | $4.6B | +53% |
| Q4 2025 | $2.8B | +17% |
| Q3 2025 | $3B | +23% |
| Q2 2025 | $2.9B | +29% |
| Q1 2025 | $3B | +42% |
| Q4 2024 | $2.4B | +67% |
OSCR has the edge over POCI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 3.5% | +7.8 points |
| Q2 2026 | 8% | +16 points |
| Q1 2026 | 15% | +5.4 points |
| Q4 2025 | -12% | -5.7 points |
| Q3 2025 | -4.3% | -2.3 points |
| Q2 2025 | -8.1% | -11 points |
| Q1 2025 | 9.8% | +1.1 points |
| Q4 2024 | -6.2% | +4 points |
OSCR has the edge over POCI on profitability, with a higher operating margin.
POCI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $8.8M | +42% |
| Q1 2026 | $8.7M | +108% |
| Q4 2025 | $7.4M | +63% |
| Q3 2025 | $6.7M | +59% |
| Q2 2025 | $6.2M | +31% |
| Q1 2025 | $4.2M | -20% |
| Q4 2024 | $4.5M | -6.2% |
| Q3 2024 | $4.2M | -2.9% |
POCI's revenue has grown year over year for five quarters in a row: $9M last quarter, up 42% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -1.2% | +21 points |
| Q1 2026 | -0.7% | +48 points |
| Q4 2025 | -24% | -3.5 points |
| Q3 2025 | -24% | +5.8 points |
| Q2 2025 | -22% | +6.8 points |
| Q1 2025 | -49% | -44 points |
| Q4 2024 | -20% | -5.5 points |
| Q3 2024 | -30% | -20 points |
POCI's operating margin was −1.2% last quarter, up 21 points from the same quarter a year ago.
OSCR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.2B | -$238.2M |
| Q2 2026 | $2.1B | +316% |
| Q1 2026 | $2.6B | +200% |
| Q4 2025 | $662.8M | +95% |
| Q3 2025 | -$973.7M | -$466M |
| Q2 2025 | $499.8M | +2.1% |
| Q1 2025 | $869.5M | +38% |
| Q4 2024 | $340M | +17% |
OSCR has the stronger cash trend. Its trailing FCF is up 545% versus its history, compared with POCI at down 5%.
POCI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q1 2026 | -$723.3K | +$1.3M |
| Q4 2025 | -$256.1K | +$560.6K |
| Q3 2025 | $78.2K | +$421.2K |
| Q2 2025 | -$615.5K | +$372.2K |
| Q1 2025 | -$2M | -$1.7M |
| Q4 2024 | -$816.6K | -$575.3K |
| Q3 2024 | -$343K | +$1.1M |
| Q2 2024 | -$987.6K | -$395.8K |
POCI has burned cash in most quarters: −$2M over the past year, against −$4M the year before.
OSCR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.9% | +13M shares |
| 1 year | +34% | +87.2M shares |
| 3 years | +55% | +123M shares |
| 5 years | +66% | +138M shares |
| Available history | +71% | +143M shares |
OSCR has 346M diluted shares, up 34% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
POCI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1% | +79.5K shares |
| 1 year | +13% | +877K shares |
| 3 years | +38% | +2.2M shares |
| 5 years | +66% | +3.1M shares |
| Available history | +82% | +3.5M shares |
POCI has the edge over OSCR on shareholder dilution, with a more favorable share count trend.
OSCR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -4.2x | Net Cash |
| Q2 2026 | -5.5x | Net Cash |
| Q1 2026 | -110.0x | Net Cash |
| Q1 2025 | -9.7x | Net Cash |
| Q4 2024 | -13.7x | Net Cash |
| Q3 2024 | -10.1x | Net Cash |
| Q2 2024 | -24.0x | Net Cash |
| Q1 2024 | -217.7x | Net Cash |
OSCR has more cash than debt.
POCI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2022 | 4.6x | High |
POCI's net debt is about 4.6 years of its operating earnings (EBITDA).
OSCR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.7 | Neutral |
| Stochastic | 44.9 | Neutral |
OSCR's weekly RSI is 59 (neutral) and its Stochastic is 45 (neutral).
POCI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.5 | Neutral |
| Stochastic | 69.4 | Neutral |
POCI's weekly RSI is 59 (neutral) and its Stochastic is 69 (neutral).
OSCR PE vs Healthcare Sector
| Metric | OSCR | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 26x | 50% below |
| PE % | 3 | 35 | 32 pts below |
OSCR is trading at 13x earnings, a 50% discount to the Healthcare sector's median of 26x, though its earnings don't support one.
POCI PE vs Healthcare Sector
| Metric | POCI | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
POCI has no meaningful PE right now: it lost money over the past year.
OSCR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $31.2 | 2.3% above |
| 20 week MA | $31.1 | 2.8% above |
| 50 week MA | $22.9 | 39% above |
| 100 week MA | $19.3 | 65% above |
| 200 week MA | $15.5 | 106% above |
OSCR has the edge over POCI on trend strength, trading above more of its moving averages.
POCI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.61 | 8.5% above |
| 20 week MA | $4.53 | 10% above |
| 50 week MA | $4.60 | 8.7% above |
| 100 week MA | $4.59 | 8.9% above |
| 200 week MA | $5.26 | 4.9% below |
POCI has bounced recently, but its long-term trend is still down: it's above its 8-, 20-, 50- and 100-week averages, but 4.9% below its 200-week average.
OSCR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $31.0 | $8.02 | -74% |
| 2022 | $8.02 | $2.21 | -72% |
| 2023 | $2.21 | $9.15 | +314% |
| 2024 | $9.15 | $13.8 | +51% |
| 2025 | $13.8 | $14.9 | +8% |
| 2026 YTD | $14.9 | $31.9 | +114% |
OSCR has the edge over POCI on returns for 2026, with the stronger performance.
POCI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.40 | $4.20 | -22% |
| 2021 | $4.20 | $7.20 | +71% |
| 2022 | $7.20 | $5.55 | -23% |
| 2023 | $5.55 | $6.02 | +8.5% |
| 2024 | $6.02 | $5.01 | -17% |
| 2025 | $5.01 | $4.21 | -16% |
| 2026 YTD | $4.21 | $5.00 | +19% |
POCI has finished lower in four of the last six years. It's up 19% so far in 2026.